- Home
- CTSO vs CEV Comparison
CTSO vs CEV Comparison
Compare CTSO & CEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTSO
- CEV
- Stock Information
- Founded
- CTSO 1997
- CEV 1999
- Country
- CTSO United States
- CEV United States
- Employees
- CTSO N/A
- CEV N/A
- Industry
- CTSO Medical/Dental Instruments
- CEV Finance/Investors Services
- Sector
- CTSO Health Care
- CEV Finance
- Exchange
- CTSO Nasdaq
- CEV Nasdaq
- Market Cap
- CTSO 72.8M
- CEV 67.8M
- IPO Year
- CTSO N/A
- CEV N/A
- Fundamental
- Price
- CTSO $0.89
- CEV $9.44
- Analyst Decision
- CTSO Buy
- CEV
- Analyst Count
- CTSO 2
- CEV 0
- Target Price
- CTSO $5.50
- CEV N/A
- AVG Volume (30 Days)
- CTSO 351.0K
- CEV 19.6K
- Earning Date
- CTSO 08-07-2025
- CEV 01-01-0001
- Dividend Yield
- CTSO N/A
- CEV 4.23%
- EPS Growth
- CTSO N/A
- CEV N/A
- EPS
- CTSO N/A
- CEV 0.36
- Revenue
- CTSO $36,107,520.00
- CEV N/A
- Revenue This Year
- CTSO $11.15
- CEV N/A
- Revenue Next Year
- CTSO $21.39
- CEV N/A
- P/E Ratio
- CTSO N/A
- CEV $29.36
- Revenue Growth
- CTSO 20.18
- CEV N/A
- 52 Week Low
- CTSO $0.71
- CEV $8.83
- 52 Week High
- CTSO $1.61
- CEV $10.91
- Technical
- Relative Strength Index (RSI)
- CTSO 41.50
- CEV 39.95
- Support Level
- CTSO $1.03
- CEV $9.48
- Resistance Level
- CTSO $1.19
- CEV $9.59
- Average True Range (ATR)
- CTSO 0.09
- CEV 0.08
- MACD
- CTSO 0.01
- CEV -0.01
- Stochastic Oscillator
- CTSO 27.21
- CEV 12.00
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
About CEV Eaton Vance California Municipal Income Trust Shares of Beneficial Interest
Eaton Vance CA Muni Income Trust is a non-diversified closed-end investment company. The company's investment objective is to provide current income exempt from regular federal income tax and California state personal income taxes. It invests in municipal obligations, issued by the State of California or its political subdivisions, agencies, authorities and instrumentalities and also has some exposure to corporate bonds.